Applied Molecular Transport Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AMTI research report →
Range $0.4 – $3
Price Chart
About the company
Applied Molecular Transport Inc. (AMTI), a biopharmaceutical company in the clinical development phase, was founded in 2010 and is based in South San Francisco, California. The firm is dedicated to discovering and advancing a pipeline of oral and respiratory biologic drug candidates, designed to address a variety of medical conditions including autoimmune, inflammatory, and metabolic diseases.
- CEO
- Shawn M. Cross
- IPO
- 2020
- Employees
- 13
- HQ
- South San Francisco, CA, US
Get TickerSpark's AI analysis on AMTI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $11.01M
- P/E
- -0.08
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.17
- EV/EBITDA
- 0.11
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -111.78%
- ROIC
- -129.95%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-127,219,000
- Net Income
- $-125,431,000-30.1%
- EPS
- $-3.23-26.2%
- OCF Growth
- -13.7%
- FCF Growth
- -16.1%
- 52W High
- $0.84
- 52W Low
- $0.13
- 50D MA
- $0.19
- 200D MA
- $0.25
- Beta
- 2.29
- RSI (14)
- 63
- Avg Volume
- 320.19K
No earnings-call transcripts are available for AMTI yet.
- Free Float
- 76.1%
- Shares Outstanding
- 41.85M
- Float Shares
- 31.86M
of shares held by institutions
25 13F filers
Buy/sell ratio 0.05. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Parametric Portfolio Associates LLC | 13.12K | ▼ 9.15K |
| Burleson & Company, LLC | 9.42K | ▼ 26.80K |
| Amalgamated Financial Corp. | 4.08K | ▲ 4.08K |
Held by 1 ETFs
Biggest fund positions in AMTI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 27, 23 | EPIQ Capital Group, LLC | other | 2,149,292 |
| Dec 27, 23 | EPIQ Capital Group, LLC | other | 3,394,948 |
| Dec 27, 23 | EPIQ Capital Group, LLC | other | 2,500,000 |
| Dec 27, 23 | EPIQ Capital Group, LLC | other | 293,278 |
| Dec 27, 23 | VanDevender Aaron | sell | 20,000 |
| Dec 27, 23 | VanDevender Aaron | sell | 20,000 |
| Dec 27, 23 | VanDevender Aaron | sell | 212,659 |
| Dec 27, 23 | VanDevender Aaron | sell | 15,395 |
| May 24, 22 | Smither John W | sell | 20,000 |
| Dec 27, 23 | Smither John W | sell | 60,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AMTI coverage
Recent articles, reports, and earnings notes.
No research on AMTI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AMTI report →Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
businesswire.com · Dec 27
APPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Molecular Transport Inc. - AMTI
businesswire.com · Nov 28
Applied Molecular Transport Reports Third Quarter 2023 Financial Results
globenewswire.com · Nov 9
APPLIED MOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Applied Molecular Transport Inc. - AMTI
businesswire.com · Sep 27
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
businesswire.com · Sep 21
Applied Molecular Transport Reports Second Quarter 2023 Financial Results
globenewswire.com · Aug 14
What Makes Applied Molecular Transport Inc. (AMTI) a New Buy Stock
zacks.com · Mar 14
Is Applied Molecular Transport (AMTI) Stock Outpacing Its Medical Peers This Year?
zacks.com · Feb 8
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.